We are live on ! Find out more
MNA

Manning & Napier Advisors Portfolio holdings

AUM $7.09B
1-Year Est. Return 17.35%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+17.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.7B
AUM Growth
+$41.2M
Cap. Flow
-$475M
Cap. Flow %
-4.07%
Top 10 Hldgs %
28.8%
Holding
332
New
20
Increased
68
Reduced
204
Closed
12

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$112M
2
CRM icon
Salesforce
CRM
+$97.7M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$85.7M
4
AMX icon
America Movil
AMX
+$79.5M
5
ABEV icon
Ambev
ABEV
+$62.7M

Sector Composition

Rank Sector Weight
1 Healthcare 25.24%
2 Technology 11.76%
3 Consumer Discretionary 11.57%
4 Communication Services 9.35%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSA
326
DELISTED
National Storage Affiliates Trust
NSA
-135,655
Closed -$3.13M
PCH
327
DELISTED
PotlatchDeltic
PCH
-41,265
Closed -$1.89M
TS icon
328
Tenaris
TS
$28.5B
-172,430
Closed -$5.37M
HMHC
329
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-2,698,414
Closed -$33.2M
DD
330
DELISTED
Du Pont De Nemours E I
DD
-14,107
Closed -$1.14M
CBPO
331
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-71,755
Closed -$8.11M
SPLS
332
DELISTED
Staples Inc
SPLS
-160,585
Closed -$1.62M

Similar funds

Manning & Napier Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Manning & Napier Advisors held 332 positions worth $11.7B, up 0.35% from $11.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Manning & Napier Advisors withdrew a net $475M in Q3 2017, closing 12 positions and reducing 204 holdings. Its most notable exit was Liberty Global Class A, an estimated $85.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Manning & Napier Advisors opened a new position in Incyte worth $125M.

  • Manning & Napier Advisors's largest Q3 2017 buy was Incyte: 1,071,325 shares worth $125M.
  • Manning & Napier Advisors added most to DaVita in Q3 2017, an estimated $113M increase.
  • Manning & Napier Advisors's biggest Q3 2017 reduction was Vertex Pharmaceuticals, cutting an estimated $112M.
  • Manning & Napier Advisors fully exited Liberty Global Class A in Q3 2017, selling an estimated $85.7M.
  • Manning & Napier Advisors's ten largest holdings make up 29% of its $11.7B portfolio in Q3 2017.
  • Manning & Napier Advisors opened 20 new positions and closed 12 in Q3 2017.
  • Manning & Napier Advisors's portfolio value rose 0.35% quarter-over-quarter to $11.7B.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.